FANJ
SRNE

Financial Architects (New Jersey)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Financial Architects (New Jersey)’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,500
Closed -$5K – 1651
2017
Q2 		$5K Hold
2,500
– – ﹤0.01% 1303
2017
Q1 		$10K Hold
2,500
– – ﹤0.01% 1148
2016
Q4 		$12K Hold
2,500
– – ﹤0.01% 972
2016
Q3 		$19K Hold
2,500
– – 0.01% 860
2016
Q2 		$14K Hold
2,500
– – ﹤0.01% 890
2016
Q1 		$13K Buy
+2,500
New +$14.5K ﹤0.01% 693

Other funds holding SRNE

WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return